Guru Ownership Trend
Guru Analysis for Trevi Therapeutics, Inc. (TRVI)
Trevi Therapeutics, Inc. (TRVI), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $59.9 M.
Top institutional holders include Andreas Halvorsen and Paul Tudor Jones.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $12.58 M net outflow during the quarter.
On the selling side, Paul Tudor Jones reduced exposure by 5.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Trevi Therapeutics, Inc. (TRVI)
Major holders include Andreas Halvorsen ($38.16 M), Paul Tudor Jones ($769,771), Cliff Asness ($335,817). According to the latest reported data, 3 tracked investment managers collectively hold approximately 3.29 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $12.58 M, with 0 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited TRVI. The total reported sell value was $12.58 M.
No tracked managers opened new positions or increased their holdings in TRVI during the most recent reporting period.